Standout Papers

ESR1 mutation as an emerging clinical biomarker in metastatic hor... 2018 2026 2020 2023 406
  1. ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer (2021)
    Jamie O. Brett, Laura M. Spring et al. Breast Cancer Research
  2. Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models (2018)
    Ioanna Keklikoglou, Chiara Cianciaruso et al. Nature Cell Biology
  3. Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future (2020)
    Laura M. Spring, Seth A. Wander et al. The Lancet

Immediate Impact

2 by Nobel laureates 7 from Science/Nature 56 standout
Sub-graph 1 of 19

Citing Papers

Ultrasound-Based Micro-/Nanosystems for Biomedical Applications
2024 Standout
Polymeric Nanoparticles for Drug Delivery
2024 Standout
2 intermediate papers

Works of Laura M. Spring being referenced

Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models
2018 Standout

Author Peers

Author Last Decade Papers Cites
Laura M. Spring 2094 1279 1162 126 3.3k
Christelle Lévy 1848 1149 1063 139 2.9k
Julia A. Beaver 2572 1414 1014 129 4.5k
Luís Manso 1809 1494 763 145 3.1k
Enzo Galligioni 1688 1173 698 164 3.4k
Toshinari Yamashita 1863 1497 1089 134 3.5k
Thomas Bachelot 1508 835 839 130 3.0k
Mario Giuliano 2376 1132 1376 107 3.7k
Erica L. Mayer 2526 966 1181 138 4.6k
Andrea Rocca 2210 886 1243 131 4.0k
Chikako Shimizu 2049 825 673 179 3.6k

All Works

Loading papers...

Rankless by CCL
2026